Rankings
▼
Calendar
GPCR FY 2021 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$40M
EPS (Diluted)
$-1.20
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$33M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$111M
Total Liabilities
$176M
Stockholders' Equity
-$65M
Cash & Equivalents
$105M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$20,034
+100.0%
Operating Income
-$38M
-$16M
-136.6%
Net Income
-$40M
-$16M
-151.6%
← FY 2020
All Quarters
Q4 2021 →